EE200300346A - Androgeensed 7-asendatud 11-halogeenosteroidid - Google Patents

Androgeensed 7-asendatud 11-halogeenosteroidid

Info

Publication number
EE200300346A
EE200300346A EEP200300346A EEP200300346A EE200300346A EE 200300346 A EE200300346 A EE 200300346A EE P200300346 A EEP200300346 A EE P200300346A EE P200300346 A EEP200300346 A EE P200300346A EE 200300346 A EE200300346 A EE 200300346A
Authority
EE
Estonia
Prior art keywords
halogenosteroids
androgenic
substituted
Prior art date
Application number
EEP200300346A
Other languages
English (en)
Inventor
Bohlmann Rolf
K�nzer Hermann
Nubbemeyer Reinhard
Zopf Dieter
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of EE200300346A publication Critical patent/EE200300346A/et
Publication of EE05274B1 publication Critical patent/EE05274B1/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EEP200300346A 2001-01-24 2002-01-24 Androgeensed 7-asendatud 11-halogenosteroidid ja neid sisaldavad farmatseutilised kompositsioonid EE05274B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104327A DE10104327A1 (de) 2001-01-24 2001-01-24 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
PCT/EP2002/000722 WO2002059139A1 (en) 2001-01-24 2002-01-24 Androgenic 7-substituted 11-halogen steroids

Publications (2)

Publication Number Publication Date
EE200300346A true EE200300346A (et) 2003-12-15
EE05274B1 EE05274B1 (et) 2010-02-15

Family

ID=7672351

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300346A EE05274B1 (et) 2001-01-24 2002-01-24 Androgeensed 7-asendatud 11-halogenosteroidid ja neid sisaldavad farmatseutilised kompositsioonid

Country Status (35)

Country Link
US (1) US7361645B2 (et)
EP (1) EP1353938B1 (et)
JP (1) JP4339591B2 (et)
KR (1) KR100728088B1 (et)
CN (1) CN1234721C (et)
AR (1) AR053299A1 (et)
AT (1) ATE386045T1 (et)
AU (1) AU2002238516B2 (et)
BG (1) BG66133B1 (et)
BR (1) BR0206653A (et)
CA (1) CA2434187C (et)
CY (1) CY1110377T1 (et)
CZ (1) CZ303553B6 (et)
DE (2) DE10104327A1 (et)
DK (1) DK1353938T3 (et)
EA (1) EA006674B1 (et)
EE (1) EE05274B1 (et)
ES (1) ES2300431T3 (et)
HK (1) HK1064678A1 (et)
HR (1) HRP20030661B1 (et)
HU (1) HUP0303020A3 (et)
IL (2) IL156807A0 (et)
MX (1) MXPA03006578A (et)
NO (1) NO325754B1 (et)
NZ (1) NZ527041A (et)
PE (1) PE20020848A1 (et)
PL (1) PL207582B1 (et)
PT (1) PT1353938E (et)
RS (1) RS50740B (et)
SK (1) SK287444B6 (et)
TW (1) TWI333494B (et)
UA (1) UA75907C2 (et)
UY (1) UY27133A1 (et)
WO (1) WO2002059139A1 (et)
ZA (1) ZA200306537B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10234525A1 (de) * 2002-07-25 2004-02-05 Schering Ag Zusammensetzung, enthaltend ein androgenes 11ß-Halogensteroid und ein Gestagen sowie männliches Kontrazeptivum auf Basis dieser Zusammensetzung
DE10233723A1 (de) 2002-07-24 2004-02-12 Schering Ag Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
MXPA05001024A (es) * 2002-07-24 2005-05-16 Schering Ag Metodo microbiologico para la produccion de 11 alfa-hdiroxiesteroides sustituidos en la posicion 7 alfa.
JP2006502997A (ja) * 2002-07-25 2006-01-26 シエーリング アクチエンゲゼルシャフト アンドロゲン11β‐ハロゲンステロイドおよびゲスタゲンを含有する組成物ならびにこの組成物に基づく男性用避妊薬
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US7879357B2 (en) * 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
CN106188202B (zh) * 2014-10-08 2017-10-24 常州大学 副产3,17‑二醇物含量大幅降低的合成睾酮方法
TWI530504B (zh) * 2014-12-01 2016-04-21 臺灣永光化學工業股份有限公司 烷基酸睾酮化合物之合成方法
US20220411460A1 (en) * 2021-06-29 2022-12-29 Board Of Regents, The University Of Texas System Modified glucocorticoids

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB863661A (en) 1958-06-06 1961-03-22 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
CH380118A (de) * 1959-06-17 1964-07-31 Ciba Geigy Neue Halogenandrostenverbindungen und Verfahren zu deren Herstellung
FR1489519A (fr) 1965-08-16 1967-07-21 Glaxo Lab Ltd Procédé de préparation de nouveaux 19-nor-stéroïdes et produits obtenus
GB1159434A (en) * 1965-08-16 1969-07-23 Glaxo Lab Ltd 11beta&;-Fluoro-19-nor-Steroids
US3665021A (en) 1966-07-29 1972-05-23 Glaxo Lab Ltd 9alpha-unsubstituted-11beta-chloro-l9 nos-steroids
GB1260463A (en) 1968-01-29 1972-01-19 Glaxo Lab Ltd 11beta-BROMO-19-NOR-STEROIDS
DE2410443A1 (de) * 1974-03-01 1975-09-11 Schering Ag 11beta-fluor-androstene
DE2410442A1 (de) 1974-03-01 1975-09-11 Schering Ag Verfahren zur herstellung von 11-fluorandrostenen
DE3214690A1 (de) * 1982-04-16 1983-10-27 Schering AG, 1000 Berlin und 4709 Bergkamen 11ss-chlor-(delta)(pfeil hoch)1(pfeil hoch)(pfeil hoch)5(pfeil hoch)-steroide, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
GB8721384D0 (en) * 1987-09-11 1987-10-21 Erba Farmitalia 17-substituted andro-sta-1 4-dien-3-one derivatives
US5342834A (en) * 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
US6767902B2 (en) * 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US5952319A (en) * 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
JP4749550B2 (ja) * 1999-03-08 2011-08-17 ナームローゼ・フエンノートチヤツプ・オルガノン アンドロゲンとしての14β,17α−ヒドロキシメチルアンドロスタン誘導体
US6756366B1 (en) * 1999-04-06 2004-06-29 Akzo Nobel N.V. Orally active androgens
DE19959696A1 (de) * 1999-12-08 2001-06-21 Jenapharm Gmbh Ungesättigte 14,15-Cyclopropano-Androstane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
PE20020848A1 (es) 2002-10-26
PL361730A1 (en) 2004-10-04
PT1353938E (pt) 2008-04-29
HUP0303020A2 (hu) 2003-12-29
PL207582B1 (pl) 2011-01-31
US7361645B2 (en) 2008-04-22
BR0206653A (pt) 2004-02-03
CZ20032006A3 (cs) 2004-01-14
NO20033321L (no) 2003-09-24
CA2434187A1 (en) 2002-08-01
EE05274B1 (et) 2010-02-15
TWI333494B (en) 2010-11-21
NO20033321D0 (no) 2003-07-23
CZ303553B6 (cs) 2012-12-05
DK1353938T3 (da) 2008-05-26
UY27133A1 (es) 2002-07-31
EA006674B1 (ru) 2006-02-24
KR100728088B1 (ko) 2007-06-14
EA200300756A1 (ru) 2004-02-26
RS50740B (sr) 2010-08-31
CY1110377T1 (el) 2015-04-29
BG108023A (bg) 2004-02-27
DE60224982D1 (de) 2008-03-27
IL156807A (en) 2008-08-07
JP4339591B2 (ja) 2009-10-07
NZ527041A (en) 2005-02-25
EP1353938A1 (en) 2003-10-22
MXPA03006578A (es) 2003-09-22
SK287444B6 (sk) 2010-09-07
DE10104327A1 (de) 2002-07-25
DE60224982T2 (de) 2009-04-09
BG66133B1 (bg) 2011-06-30
NO325754B1 (no) 2008-07-14
WO2002059139A1 (en) 2002-08-01
CA2434187C (en) 2009-06-16
YU59403A (sh) 2006-08-17
KR20030081391A (ko) 2003-10-17
EP1353938B1 (en) 2008-02-13
US20050075322A1 (en) 2005-04-07
AU2002238516B2 (en) 2007-08-23
CN1234721C (zh) 2006-01-04
ATE386045T1 (de) 2008-03-15
IL156807A0 (en) 2004-02-08
SK9542003A3 (en) 2003-12-02
CN1487950A (zh) 2004-04-07
HRP20030661A2 (en) 2005-06-30
HRP20030661B1 (en) 2011-10-31
JP2004517153A (ja) 2004-06-10
UA75907C2 (en) 2006-06-15
ES2300431T3 (es) 2008-06-16
ZA200306537B (en) 2004-09-08
AR053299A1 (es) 2007-05-02
HK1064678A1 (en) 2005-02-04
HUP0303020A3 (en) 2012-03-28

Similar Documents

Publication Publication Date Title
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
DE60214255D1 (de) Schlussstück
ATE335486T1 (de) Hydrazono-malonitrile
NO20014597D0 (no) Fremgangsmåte
DE60238924D1 (de) Abwälzfräser
ATE355059T1 (de) Isoxazolopyridinone
EE200300346A (et) Androgeensed 7-asendatud 11-halogeenosteroidid
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
ITRE20010085A0 (it) Indumento intimo
DE50212755D1 (de) Bohrfutter
ATA13992002A (de) Schlackengranulierungsanlage
ATA2892002A (de) Beschlag
NO20041687L (no) Sluttstykke
ATE345337T1 (de) Delta1 -pyrroline
AT500276B1 (de) Radschwenksystem
ATA7462001A (de) Radspannwerk
ATA15932001A (de) Leuchte
DE10196706D2 (de) Nagelfeile
ATA6162001A (de) Schneekette
DK1350054T3 (da) Aftapningsfitting
FI5213U1 (fi) Valaisin
ES1048238Y (es) Lampara
FIU20010205U0 (fi) Teline
SE0103700D0 (sv) Uppsättning

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20140124